Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Semi Synthetic Modification. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106674242B details novel curcumol derivatives with enhanced solubility and anti-tumor activity, offering cost reduction in API manufacturing and scalable supply solutions.
Patent CN114524830B reveals a breakthrough process for vinorelbine tartrate, replacing chromatography with crystallization for superior yield and scalable manufacturing.
Patent CN105693815A details a novel synthesis route for high-purity piperazine-modified ursolic acid derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101353333B details a novel synthesis route for paclitaxel analogues offering high yield and reduced multidrug resistance for reliable pharmaceutical intermediate supply chains.
Advanced semi-synthetic route from vincamine ensures high purity and yield, offering significant cost reduction in pharmaceutical manufacturing for global buyers.
Patent CN110105368B reveals novel deoxy taxane synthesis improving solubility and anticancer activity, offering cost-effective API intermediate manufacturing strategies.
Patent CN102558105A discloses a novel semi-synthetic route for taxol analogs using abundant 1-dehydroxybaccatin VI. This method improves solubility and reduces multidrug resistance.
Advanced semi-synthetic route for Vinpocetine ensuring high purity and yield. Cost-effective manufacturing solution for global pharmaceutical supply chains.
Patent CN112679570A details a robust synthesis of Tildipirosin from Tylosin phosphate, offering high purity >99% and simplified purification for reliable veterinary drug intermediate supply chains.
Advanced one-step preparation of Vindesine Sulfate from Vinblastine. Offers high purity, reduced byproducts, and cost-effective scalability for pharmaceutical manufacturing.
Patent CN106167474A details a high-yield Azitaxel synthesis using 10-DAB, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel synthesis of (25R)-5α-cholesta-2β,3α,26-triol from tigogenin. Scalable route for pharma intermediates with high purity and cost efficiency.
Advanced synthesis of C-13 and C-14 modified taxane derivatives via patent CN107188895B. Offers improved anticancer activity and reduced toxicity for reliable pharmaceutical intermediate supply.
Novel semi-synthetic route from epibrassinolide ensures high purity and scalability. Ideal for plant growth regulator manufacturing and cost reduction.
Advanced semi-synthetic route for high-purity Vinpocetine intermediates. Reduces cost and environmental impact. Ideal for pharmaceutical manufacturing.
Patent CN112724189A details a novel semi-synthetic route for Chenodeoxycholic Acid from waste bile acids, offering significant cost reduction and supply chain stability for API manufacturers.